Typing of Mycobacterium tuberculosis strains resistant to rifampicin and isoniazid by molecular biological methods. 2003

O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
Moscow Tuberculosis Control Center, Moscow Public Health Committee.

Mutations in the rpoB, katG, inhA, oxyR/ahpC genes in rifampicin- and isoniazid-resistant M. tuberculosis strains isolated from residents of Moscow, Astrakhan', and Moldova Republic were studied by molecular biological methods (heteroduplex analysis, single strand conformational polymorphism, biochips). Twenty-five combinations of mutations were detected. Some differences in the type distribution of detected mutations were found. The use of biochips is the most perspective method for determining the type of mutation.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009692 Nucleic Acid Heteroduplexes Double-stranded nucleic acid molecules (DNA-DNA or DNA-RNA) which contain regions of nucleotide mismatches (non-complementary). In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids. Heteroduplexes, Nucleic Acid,Heteroduplex DNA,Acid Heteroduplexes, Nucleic,DNA, Heteroduplex
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
January 2011, Japanese journal of infectious diseases,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
January 2000, Problemy tuberkuleza,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
January 2013, Enfermedades infecciosas y microbiologia clinica,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
December 2016, International journal of mycobacteriology,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
January 1957, Problemy tuberkuleza,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
January 2015, Enfermedades infecciosas y microbiologia clinica,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
August 1981, Journal of clinical pathology,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
May 1953, Lancet (London, England),
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
December 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
O I Skotnikova, and E Yu Nosova, and O V Markova, and O A Irtuganova, and V N Krudu, and S S Ginda, and O V Golishcheva, and M N Biryukova, and E N Strel'tsova, and O V Kalyanina, and V I Litvinov, and A M Moroz, and S A Lapa, and D A Gryadunov, and V M Mikhailovich
May 2015, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!